These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26849157)

  • 21. Outcomes of a nurse-managed service for stable HIV-positive patients in a large South African public sector antiretroviral therapy programme.
    Grimsrud A; Kaplan R; Bekker LG; Myer L
    Trop Med Int Health; 2014 Sep; 19(9):1029-39. PubMed ID: 25041716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two-year death and loss to follow-up outcomes by source of referral to HIV care for HIV-infected patients initiating antiretroviral therapy in rural Mozambique.
    Blevins M; José E; Bilhete FR; Vaz LM; Shepherd BE; Audet CM; Vermund SH; Moon TD
    AIDS Res Hum Retroviruses; 2015 Feb; 31(2):198-207. PubMed ID: 25381732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effective public-private partnerships for sustainable antiretroviral therapy: outcomes of the Right to Care health services GP down-referral program.
    Mokhele I; Mashamaite S; Majuba P; Xulu T; Long L; Onoya D
    BMC Public Health; 2019 Nov; 19(1):1471. PubMed ID: 31699063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes Among Children Enrolled in HIV Care in Mozambique 2009-2013.
    Teasdale CA; Yang J; Thome B; Yersin I; Sebastian T; Brusamento S; Lahuerta M; Jobarteh KM; Abrams EJ
    Pediatr Infect Dis J; 2016 Oct; 35(10):1117-25. PubMed ID: 27622685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of adverse outcomes in HIV-1-infected children receiving combination antiretroviral treatment: results from a DREAM cohort in sub-Saharan Africa.
    Marazzi MC; De Luca S; Palombi L; Scarcella P; Ciccacci F; Ceffa S; Nielsen-Saines K; De Luca A; Mancinelli S; Gennaro E; Zimba I; Liotta G; Buonomo E
    Pediatr Infect Dis J; 2014 Mar; 33(3):295-300. PubMed ID: 23799517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patient-level benefits associated with decentralization of antiretroviral therapy services to primary health facilities in Malawi and Uganda.
    Abongomera G; Chiwaula L; Revill P; Mabugu T; Tumwesige E; Nkhata M; Cataldo F; van Oosterhout J; Colebunders R; Chan AK; Kityo C; Gilks C; Hakim J; Seeley J; Gibb DM; Ford D
    Int Health; 2018 Jan; 10(1):8-19. PubMed ID: 29329396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of antiretroviral therapy over a 10-year period of expansion: a multicohort analysis of African and Asian HIV programs.
    Grimsrud A; Balkan S; Casas EC; Lujan J; Van Cutsem G; Poulet E; Myer L; Pujades-Rodriguez M
    J Acquir Immune Defic Syndr; 2014 Oct; 67(2):e55-66. PubMed ID: 24977472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of decentralizing anti-retroviral services in Nigeria on costs and service utilization: two case studies.
    Johns B; Baruwa E
    Health Policy Plan; 2016 Mar; 31(2):182-91. PubMed ID: 25989806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retention of HIV infected pregnant and breastfeeding women on option B+ in Gomba District, Uganda: a retrospective cohort study.
    Kiwanuka G; Kiwanuka N; Muneza F; Nabirye J; Oporia F; Odikro MA; Castelnuovo B; Wanyenze RK
    BMC Infect Dis; 2018 Oct; 18(1):533. PubMed ID: 30355356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determinants of loss to follow-up in patients on antiretroviral treatment, South Africa, 2004-2012: a cohort study.
    Mberi MN; Kuonza LR; Dube NM; Nattey C; Manda S; Summers R
    BMC Health Serv Res; 2015 Jul; 15():259. PubMed ID: 26141729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gender-related differences in outcomes and attrition on antiretroviral treatment among an HIV-infected patient cohort in Zimbabwe: 2007-2010.
    Takarinda KC; Harries AD; Shiraishi RW; Mutasa-Apollo T; Abdul-Quader A; Mugurungi O
    Int J Infect Dis; 2015 Jan; 30():98-105. PubMed ID: 25462184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Barriers to antiretroviral therapy initiation for HIV-positive children aged 2-18 months in Swaziland.
    Jolly P; Padilla LA; Ahmed C; Harris C; Mthethwa N; Jha M; Ba I; Styles A; Hope SP; Brooks R; Naluyinda-Kitabire F; Mamba M; Preko P
    Afr J AIDS Res; 2018 Jul; 17(2):193-202. PubMed ID: 30003844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD4 count at antiretroviral therapy initiation and the risk of loss to follow-up: results from a multicentre cohort study.
    Grimsrud A; Cornell M; Schomaker M; Fox MP; Orrell C; Prozesky H; Stinson K; Tanser F; Egger M; Myer L;
    J Epidemiol Community Health; 2016 Jun; 70(6):549-55. PubMed ID: 26700300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pediatric Access and Continuity of HIV Care Before the Start of Antiretroviral Therapy in Sub-Saharan Africa.
    Bastard M; Poulet E; Nicolay N; Szumilin E; Balkan S; Pujades-Rodriguez M
    Pediatr Infect Dis J; 2016 Sep; 35(9):981-6. PubMed ID: 27187757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Age at Antiretroviral Therapy Initiation on Catch-up Growth Within the First 24 Months Among HIV-infected Children in the IeDEA West African Pediatric Cohort.
    Jesson J; Koumakpaï S; Diagne NR; Amorissani-Folquet M; Kouéta F; Aka A; Lawson-Evi K; Dicko F; Kouakou K; Pety T; Renner L; Eboua T; Coffie PA; Desmonde S; Leroy V;
    Pediatr Infect Dis J; 2015 Jul; 34(7):e159-68. PubMed ID: 25955835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment Failure in HIV-Infected Children on Second-line Protease Inhibitor-Based Antiretroviral Therapy.
    Suaysod R; Ngo-Giang-Huong N; Salvadori N; Cressey TR; Kanjanavanit S; Techakunakorn P; Krikajornkitti S; Srirojana S; Laomanit L; Chalermpantmetagul S; Lallemant M; Le Cœur S; McIntosh K; Traisathit P; Jourdain G
    Clin Infect Dis; 2015 Jul; 61(1):95-101. PubMed ID: 25838288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Four-year retention and risk factors for attrition among members of community ART groups in Tete, Mozambique.
    Decroo T; Koole O; Remartinez D; dos Santos N; Dezembro S; Jofrisse M; Rasschaert F; Biot M; Laga M
    Trop Med Int Health; 2014 May; 19(5):514-21. PubMed ID: 24898272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss to follow-up before and after initiation of antiretroviral therapy in HIV facilities in Lilongwe, Malawi.
    Tweya H; Oboho IK; Gugsa ST; Phiri S; Rambiki E; Banda R; Mwafilaso J; Munthali C; Gupta S; Bateganya M; Maida A
    PLoS One; 2018; 13(1):e0188488. PubMed ID: 29373574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss to follow-up and mortality among HIV-infected adolescents receiving antiretroviral therapy in Pune, India.
    Nimkar S; Valvi C; Kadam D; Rewari BB; Kinikar A; Gupte N; Suryavanshi N; Deluca A; Shankar A; Golub J; Bollinger R; Gupta A; Marbaniang I; Mave V
    HIV Med; 2018 Jul; 19(6):395-402. PubMed ID: 29573312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low risk of death, but substantial program attrition, in pediatric HIV treatment cohorts in Sub-Saharan Africa.
    KIDS-ART-LINC Collaboration
    J Acquir Immune Defic Syndr; 2008 Dec; 49(5):523-31. PubMed ID: 18989227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.